Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 161-167 , April 2010

A call to arms: Using RNAi screening to improve oncolytic viral therapy

  • D.J. Mahoney

      Affiliations

    • Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada
    • Department of Pediatrics, University of Ottawa, Ottawa, ON K1H 8L1, Canada
  • ,
  • D.F. Stojdl

      Affiliations

    • Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada
    • Department of Pediatrics, University of Ottawa, Ottawa, ON K1H 8L1, Canada
    • Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON K1H 8L1, Canada
    • Corresponding Author InformationCorresponding author at: Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada. Tel.: +1 613 738 4179; fax: +1 613 738 4833.

References 

  1. Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE. Oncolytic viruses in cancer therapy. Cancer Lett. 2007;254:178–216
  2. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009;136:823–837
  3. Stojdl DF, Lichty B, Knowles S, et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med. 2000;6:821–825
  4. Coffey MC, Strong JE, Forsyth PA, Lee PW. Reovirus therapy of tumors with activated Ras pathway. Science. 1998;282:1332–1334
  5. Stojdl DF, Lichty BD, tenOever BR, et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell. 2003;4:263–275
  6. Peng X, Chan EY, Li Y, Diamond DL, Korth MJ, Katze MG. Virus–host interactions: from systems biology to translational research. Curr Opin Microbiol. 2009;12:432–438
  7. Cherry S. What have RNAi screens taught us about viral–host interactions?. Curr Opin Microbiol. 2009;12:446–452
  8. Moffat J, Sabatini DM. Building mammalian signalling pathways with RNAi screens. Nat Rev Mol Cell Biol. 2006;7:177–187
  9. Zhou H, Xu M, Huang Q, et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe. 2008;4:495–504
  10. Brass AL, Dykxhoorn DM, Benita Y, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science. 2008;319:921–926
  11. Konig R, Zhou Y, Elleder D, et al. Global analysis of host–pathogen interactions that regulate early-stage HIV-1 replication. Cell. 2008;135:49–60
  12. Yeung ML, Houzet L, Yedavalli VS, Jeang KT. A genome-wide short hairpin RNA screening of Jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem. 2009;284:19463–19473
  13. Brass AL, Huang I-C, Benita Y, et al. The IFITM proteins mediate cellular resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus. Cell. 2009;139:1243–1254
  14. Shapira SD, Gats-Viks I, Shum B, et al. A Physical and regulatory map of host–influenza interactions reveals pathways in H1Ni infection. Cell. 2009;139
  15. Carette JE, Guimaraes CP, Varadarajan M, et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science. 2009;326:1231–1235
  16. Hao L, Sakurai A, Watanabe T, et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature. 2008;454:890–893
  17. Konig R, Stertz S, Zhou Y, et al. Human host factors required for influenza virus replication. Nature. 2009;
  18. Ng TI, Mo H, Pilot-Matias T, et al. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology. 2007;45:1413–1421
  19. Randall G, Panis M, Cooper JD, et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA. 2007;104:12884–12889
  20. Berger KL, Cooper JD, Heaton NS, et al. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc Natl Acad Sci USA. 2009;106:7577–7582
  21. Coller KE, Berger KL, Heaton NS, Cooper JD, Yoon R, Randall G. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog. 2009;5:e1000702
  22. Krishnan MN, Ng A, Sukumaran B, et al. RNA interference screen for human genes associated with West Nile virus infection. Nature. 2008;455:242–245
  23. Sessions OM, Barrows NJ, Souza-Neto JA, et al. Discovery of insect and human dengue virus host factors. Nature. 2009;458:1047–1050
  24. Pelkmans L, Fava E, Grabner H, et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature. 2005;436:78–86
  25. Novina CD, Sharp PA. The RNAi revolution. Nature. 2004;430:161–164
  26. Sharp PA. RNAi and double-strand RNA. Genes Dev. 1999;13:139–141
  27. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–811
  28. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291:1304–1351
  29. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921
  30. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science. 1998;282:2012–2018
  31. Adams MD, Celniker SE, Holt RA, et al. The genome sequence of Drosophila melanogaster. Science. 2000;287:2185–2195
  32. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature. 2000;408:325–330
  33. Kamath RS, Fraser AG, Dong Y, et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 2003;421:231–237
  34. Ashrafi K, Chang FY, Watts JL, et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature. 2003;421:268–272
  35. Ramet M, Manfruelli P, Pearson A, Mathey-Prevot B, Ezekowitz RA. Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature. 2002;416:644–648
  36. Bettencourt-Dias M, Giet R, Sinka R, et al. Genome-wide survey of protein kinases required for cell cycle progression. Nature. 2004;432:980–987
  37. Boutros M, Kiger AA, Armknecht S, et al. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science. 2004;303:832–835
  38. Kittler R, Putz G, Pelletier L, et al. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature. 2004;432:1036–1040
  39. Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature. 2004;428:431–437
  40. Bushman FD, Malani N, Fernandes J, et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009;5:e1000437
  41. Goff SP. Knockdown screens to knockout HIV-1. Cell. 2008;135:417–420
  42. Ngo VN, Davis RE, Lamy L, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 2006;441:106–110
  43. Bernards R, Brummelkamp TR, Beijersbergen RL. shRNA libraries and their use in cancer genetics. Nat Methods. 2006;3:701–706
  44. Luo J, Emanuele MJ, Li D, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell. 2009;137:835–848
  45. Scholl C, Frohling S, Dunn IF, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell. 2009;137:821–834
  46. Tang W, Dodge M, Gundapaneni D, Michnoff C, Roth M, Lum L. A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci USA. 2008;105:9697–9702
  47. Chung N, Zhang XD, Kreamer A, et al. Median absolute deviation to improve hit selection for genome-scale RNAi screens. J Biomol Screen. 2008;13:149–158
  48. Birmingham A, Selfors LM, Forster T, et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods. 2009;6:569–575

PII: S1359-6101(10)00024-9

doi: 10.1016/j.cytogfr.2010.02.013

Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 161-167 , April 2010